(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.15%) $78.36
(1.18%) $2.22
(-0.38%) $2 322.40
(-0.49%) $27.48
(2.41%) $988.15
(0.16%) $0.930
(0.74%) $10.90
(0.43%) $0.799
(0.21%) $91.54
3 days till quarter result
(bmo 2024-05-10)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex diagnostic testing products for the In-Vitro diagnostics market...
Stats | |
---|---|
本日の出来高 | 31 300.00 |
平均出来高 | 59 845.00 |
時価総額 | 1.66B |
EPS | TWD0 ( 2024-03-15 ) |
次の収益日 | ( TWD0 ) 2024-05-10 |
Last Dividend | TWD0 ( N/A ) |
Next Dividend | TWD0 ( N/A ) |
P/E | -10.07 |
ATR14 | TWD0.0390 (0.19%) |
Applied BioCode 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Applied BioCode 財務諸表
Annual | 2023 |
収益: | TWD395.17M |
総利益: | TWD223.53M (56.57 %) |
EPS: | TWD-2.01 |
FY | 2023 |
収益: | TWD395.17M |
総利益: | TWD223.53M (56.57 %) |
EPS: | TWD-2.01 |
FY | 2022 |
収益: | TWD390.30M |
総利益: | TWD234.17M (60.00 %) |
EPS: | TWD-2.26 |
FY | 2021 |
収益: | TWD319.96M |
総利益: | TWD189.37M (59.18 %) |
EPS: | TWD-2.02 |
Financial Reports:
No articles found.
Applied BioCode
Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex diagnostic testing products for the In-Vitro diagnostics market. The company's products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testing; and the BioCode 2500 analyzer, a system that reads barcoded magnetic beads (BMB) and displays the barcode and fluorescence intensity for each BMB. In addition, It develops assays, such as BioCode SARS-CoV-2 Assay, a high volume automated nucleic acid multiplex assay for the detection of SARS-CoV-2 nucleic acid in nasopharyngeal swabs; BioCode Respiratory Pathogen Panels, which simultaneously detects and differentiates the presence of 17 respiratory pathogens in nasopharyngeal swabs; BioCode gastrointestinal (GI) pathogen panels for common GI pathogens, including viruses, bacteria, and parasites that cause infectious diarrhea; and MDx assays pipeline for various molecular tests. Further, the company offers fungal pathogen analyte specific reagents; human cytokine/chemokine multiplex kits to identify relevant biomarkers; mouse premixed multiplex kits and custom panels for enhancing flexibility in experimental design allowing the user to pick and choose their own analytes panel; and rat, monkey, canine, and non-human primate cytokine/chemokine multiplex kits. Additionally, the company provides BMB, calibration beads, and coupling kits for various bioassay applications; ELISA, a tool for the quantitative measurement of drug/protein/antibody levels in biological samples comprising cell lysate or serum; and various assay development services. Applied BioCode Corporation is based in Santa Fe Springs, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。